NCT07552298 The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia
| NCT ID | NCT07552298 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University |
| Condition | Coccydynia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-15 |
| Primary Completion | 2026-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-15 with a primary completion date of 2026-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this prospective, randomized, controlled, double-blinded study, we aimed to evaluate the effects of Dextrose Prolotherapy injections in patients with coccydynia.
Eligibility Criteria
Inclusion Criteria: * Patients with coccydynia lasting longer than 6 months, * Those unresponsive to at least 6 months of conventional conservative treatment methods, * Those with coccygeal tenderness on palpation, * Patients aged between 18 and 65 years. Exclusion Criteria: * Patients with a history of trauma within the last 3 months or postpartum coccydynia, * Those with lesions or infections at the injection site, * Those with dislocation or organic bone pathology of the coccyx observed on X-ray imaging, * Those with fecal or urinary incontinence, * Patients with poorly controlled diabetes mellitus, * Those with a history of malignancy, * Patients with a bleeding tendency (acquired or hereditary) \[INR \> 2 in patients using warfarin\], * Those with a history of myelomeningocele, * Those diagnosed with spina bifida, * Patients with rheumatologic disease, * Those who have undergone coccyx injection or ganglion block within the last 3 months, * Patients with severe comorbidities.
Contact & Investigator
Ekin I Sen, Assoc.Prof.
PRINCIPAL INVESTIGATOR
Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation
Frequently Asked Questions
Who can join the NCT07552298 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Coccydynia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07552298 currently recruiting?
Yes, NCT07552298 is actively recruiting participants. Contact the research team at ekinozgorgu@gmail.com for enrollment information.
Where is the NCT07552298 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07552298 clinical trial?
NCT07552298 is sponsored by Istanbul University. The principal investigator is Ekin I Sen, Assoc.Prof. at Istanbul University Istanbul Faculty of Medicine, Department of Physical Medicine and Rehabilitation. The trial plans to enroll 40 participants.